440
Participants
Start Date
October 21, 2019
Primary Completion Date
September 1, 2021
Study Completion Date
November 29, 2021
Fluconazole Tablet
150 mg every 72 hours for 3 doses
IBREXAFUNGERP
300 mg BID (one day) every 4 weeks for a total of 6 dosing days
Placebo oral tablet
BID (one day) every 4 weeks for a total of 6 dosing days
Obstetrics and Gynecology Associates of Erie, PC, Erie
Jefferson University Hospital, Philadelphia
Unified Women's Clinical Research, Hagerstown
Group For Women, Winston-Salem
Lyndhurst Clinical Research, Winston-Salem
Unified Womens CLinical Research, Greensboro
Unified Women's Clinical Research Raleigh, Raleigh
M3 Wake Research, Inc, Raleigh
Carolina Women's Research and Wellness Center, Durham
Healthcare Clinical Data Inc, North Miami
New Age Medical Research Corporation, Miami
Altus Research - Hunt - PPDS, Lake Worth
Chattanooga Medical Research Inc, Chattanooga
Medical Research Center of Memphis, LLC, Memphis
Cleveland Clinic, Cleveland
Wayne State University, Detroit
Women Under Study, LLC, New Orleans
Clinical Trials Management, Covington
TMC Life Research Inc, Houston
Clinical Research Prime - ClinEdge - PPDS, Idaho Falls
Precision Trials LLC, Phoenix
Bosque Women's Care, Albuquerque
Women's Healthcare Research Corp, San Diego
Center For Women's Health and Wellness LLC, Lawrenceville
Lawrence Obstetrics Gynecology Clinical Research LLC, Lawrenceville
Scynexis, Inc.
INDUSTRY